British National Formulary (BNF) 70

This Medical Association and Royal Pharmaceutical Society of Great Britain app-book is developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using MedHand’s patented technology.

THIS APP-BOOK for BNF 70includes unique functions such as:

• A powerful search
• Bookmarks
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Highlighting
• History
• Notes and picture notes

The British National Formulary (BNF) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.The resource includes:

• Guidance on the drug management of common conditions
• Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient.
• Guidance on prescribing, monitoring, dispensing and adminstering medicines.

BNF 70 (September 2015) has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.

To make it even easier to find the information you need, the content in the new BNF 70 has been restructured.

You’ll find improved consistency and clarity in the print version. See www.bnf.org to find out more, along with sample pages and a clear guide on how to use the improved BNF.

Some of the significant content updates in this edition include:

• New safety information about reducing the risk of QT interval prolongation and Torsade de Pointes with hydroxyzine
• New advice about the risk of lymphopenia and potential risk of progressive multifocal leukoencephalopathy with dimethyl fumarate
• Further guidance on the restricted use of codeine for the treatment of cough and cold symptoms in children
• Addition of new indications for omalizumab for treating chronic spontaneous urticaria and for lenalidomide in certain patients with multiple myeloma
• Updated dosing information for the use of tramadol in the treatment of acute and chronic pain
• Guidance about dose reduction for lisdexamfetaminemesilate for patients with severe renal impairment
• Updated contra-indications for aceclofenac in patients with certain established cardiovascular diseases
• Addition of new preparations, including DuoRespSpiromax® (budesonide with formoterol), Envarsus® (tacrolimus), FostairNEXThaler® (beclometasone with formoterol), Jaydess® (levonorgestrel), Ketoconazole HRA® (ketoconazole) and Lonquex® (lipegfilgrastim)

The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.


Authors: Joint Formulary Committee

________________________________________

Important information: This app will be removed from sale when newer edition have been released.

MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade.

MedHand has created user-friendly, quick and intuitive applications which have been honored with numerous 5 star reviews praising the interface and layout. Offering the most trusted and well recognized medical guidelines provided by excellent publishers. MedHand delivers what you need, trusted knowledge at the point of care!

MedHand are presenting latest editions from renowned publishers such as Oxford University Press, McGraw-Hill, Royal Pharmaceutical Society, PDR Network LLC, Wiley and more